A61K - Preparations for medical, dental, or toilet purposes

More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)

Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
11/2001
11/29/2001	WO2001089463A2 Effervescent whitening dentifrice having sensory signal based on the release or oxygen
11/29/2001	WO2001089457A2 Thrombopoietin mimetics
11/29/2001	WO2000041548A3 Methods for glucagon suppression
11/29/2001	US20010047105 EP4 receptor selective agonists in the treatment of osteoporosis
11/29/2001	US20010046995 React with alkylating agents such as mustard gas; may contain perfluoropolymers which are effective barrier compounds for pesticides, industrial solvents and chemical warfare agents
11/29/2001	US20010046489 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
11/29/2001	US20010044977 Using mixture of an oxidoreductase and basic amino acid
11/29/2001	CA2409345A1 Effervescent whitening dentifrice having sensory signal based on the release or oxygen
11/29/2001	CA2409274A1 Emulsions with naphthalate esters
11/28/2001	EP1157689A1 Stable pharmaceutical solution formulations for pressurised metered dose inhalers
11/28/2001	EP1157094A2 Method for the purification, recovery, and sporulation of cysts and oocysts
11/28/2001	EP1157021A1 Sulfamato hydroxamic acid metalloprotease inhibitor
11/28/2001	EP1156814A2 Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain
11/28/2001	EP1156802A1 Pharmaceutic, dietetic and cosmetic compositions based on thioctic acid and cysteine
11/28/2001	EP1156776A1 Dual component dentinal desensitizing dentifrice
11/28/2001	EP0758244B1 Controlled-release dosage forms of azithromycin
11/28/2001	CN1324348A TAN-1057 derivatives
11/28/2001	CN1324347A Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use
11/28/2001	CN1324344A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
11/28/2001	CN1324233A Controlled-release pharmaceutical formulations contg. a CGMP PDE-5 inhibitor
11/27/2001	US6323194 Muscarinic agonists and antagonists
11/27/2001	US6322813 Compact member, method of manufacturing and use thereof
11/27/2001	US6322799 Benefit agent compositions comprising mixtures of α-hydroxy esters
11/22/2001	WO2001087841A1 Novel polymorph v of torasemide
11/22/2001	WO2001087237A2 Apparatus and process for in situ manufacture of essence from living, uncut plants
11/22/2001	WO2001087232A2 Allantoin-containing skin cream
11/22/2001	US20010044519 Bile sequestering polymer comprises a crosslinked, alkylated, cationic polyamine or polyallylamine homo- or co-polymer
11/22/2001	CA2409699A1 Novel polymorph v of torasemide
11/22/2001	CA2408689A1 Allantoin-containing skin cream
11/21/2001	EP1156046A1 Benzo(5,6)cyclohepta(1,2-B)pyridine derivatives for the inhibition of farnesyl protein transferase
11/21/2001	EP1155000A1 2-aminopyridines containing fused ring substituents
11/21/2001	EP1154987A1 Phenylalaninol derivatives
11/21/2001	EP1154754A1 Method to enhance peroxide tooth whitening
11/21/2001	EP0998292B1 Method for inhibiting bone resorption
11/21/2001	CN1323207A Use of ophthalmic composition comprising vitamin A and vitamin E
11/21/2001	CN1323200A New oral formulation for 5-HT4 agonists or antagonists
11/21/2001	CN1322526A Compound for treating female sexual dysfunction
11/21/2001	CN1074918C Use of Ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motion blockade
11/20/2001	US6319509 Pharmaceutical composition
11/15/2001	WO2001085190A1 Irradiation of ispaghula
11/15/2001	WO2001085171A1 Local anesthetic methods and kits
11/15/2001	WO2001085114A1 Oral composition
11/15/2001	WO2001036001A3 Interferon gamma conjugates
11/15/2001	WO2000057865A9 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
11/15/2001	WO2000051548A3 COMPOSITIONS AND METHODS FOR THEIR PREPARATION FROM $i(LEPIDIUM)
11/15/2001	US20010041964 Pharmacokinetic-based drug design tool and method
11/15/2001	US20010041720 2-Amino-N-((1R)-2-((3R)-3-benzyl-3-(N,N',N' -trimethylhydrazinocarbonyl)piperidin-1-yl)-1-(1H-indol-3-ylmethyl)-2 -oxoethyl)-2-methylpropionamide; increasing rate and extent of growth, milk and wool production
11/15/2001	DE10113328A1 New herbal composition for treating gynecological and other related disorders comprises solvent extracted herbal extract and a plant coagulate
11/15/2001	CA2407743A1 Irradiation of ispaghula
11/15/2001	CA2407687A1 Oral composition
11/14/2001	EP1153924A2 Substituted 1,3-oxathiolanes with antiviral properties
11/14/2001	EP1153610A1 Matrix protein compositions for inflammatory and infectious conditions
11/14/2001	EP1152764A1 Compositions and methods for use in targeting vascular destruction
11/14/2001	EP1152755A1 Essential fatty acids in the prevention of cardiovascular events
11/14/2001	EP1003537B1 Composition comprising propolis and at least an essential oil
11/14/2001	EP0980250B1 Plant extracts for the treatment of increased bone resorption
11/14/2001	EP0783293B1 Granular compositions
11/14/2001	EP0762883B1 Pyridylbisphosphonates for use as a therapeutical agent
11/14/2001	CN1322198A HIV replication inhibiting pyrimidines
11/13/2001	US6316504 Administering r(+)-n-propargyl-1-aminoindan or its salt for therapy of multiple sclerosis
11/13/2001	US6315986 Striped dentifrice stable to color bleeding
11/13/2001	US6315873 Method of forming a fluoride film
11/13/2001	US6315730 Ultrasound imaging of tissue perfusion by pulse energy disruption of contrast agent
11/08/2001	WO2001083484A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
11/08/2001	WO2001083470A1 Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)
11/08/2001	WO2001082869A2 Anionic vinyl/dicarboxylic acid polymers and uses thereof
11/08/2001	WO2001082866A2 Cosmetic compositions containing film forming polymers plasticized with esters of malic acid
11/08/2001	WO2001082859A2 Method for producing r-teatrol analogs having an antineoplastic activity
11/08/2001	WO2001044242A9 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamide inhibitors of cyclin dependent kinases
11/08/2001	US20010039297 Compositions and method for improving insulin sensivity and glucose metabolism in individuals with impaired fasting glucose or impaired glucose tolerance
11/08/2001	US20010039281 No drug resistance; intravenous
11/08/2001	US20010039271 For treatment of male erectile dysfunction, female sexual dysfunction
11/08/2001	CA2407535A1 Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)
11/07/2001	EP1151998A1 Estrogen agonists/antagonists
11/07/2001	EP1150991A2 Compositions for treating inflammatory response
11/07/2001	EP1150973A1 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
11/07/2001	EP1150679A1 Use of cholesterol-lowering agent
11/07/2001	EP1150678A1 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy
11/07/2001	EP1150661A2 Topical sprays comprising a film forming composition
11/07/2001	EP1150648A2 Use of water-soluble/dispersible reactive derivatives of polyimido compounds for modifying proteinaceous substrates
11/07/2001	EP0861235B1 Substituted benzylaminopiperidine compounds
11/07/2001	EP0836475B1 Controlled release formulations for poorly soluble drugs
11/07/2001	EP0799039B1 Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections
11/07/2001	EP0707479B1 Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin
11/07/2001	EP0626939B1 Tri-substituted phenyl derivatives as phosphodiesterase inhibitors
11/07/2001	CN1320426A Compound for treatment of female sexual dysfuction
11/07/2001	CN1074422C Method for preparing HCV epitope-contg. separated polypeptide
11/07/2001	CN1074414C indolylalkyl derivs. of benzodioxanmethylamine as 5-HT1A receptor ligands
11/06/2001	US6313312 3-Azabicyclo[3.1.0]hexane derivatives useful in therapy
11/06/2001	US6313146 Calcium receptor-active molecules
11/06/2001	US6313142 Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
11/06/2001	US6313100 Antibacterial, antiprotozoa agents
11/06/2001	US6312479 Oxidation base; coupler chosen from 2-amino-3-hydroxypyridines and acid-addition salts thereof; a 2-electron oxidoreductase; and a donor for said enzyme.
11/01/2001	WO2001081582A2 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same
11/01/2001	WO2001080619A2 Pharmaceutical composition containing citalopram
11/01/2001	US20010037039 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
11/01/2001	US20010036477 Oral administering
11/01/2001	US20010036476 Bioavailability; sustained release
11/01/2001	US20010036456 Administering Protein C
11/01/2001	CA2407523A1 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same

1 ... 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 ... 295